DXB 2.50% 39.0¢ dimerix limited

"they just need the phase 3 interim read-out to demonstrate that...

  1. 546 Posts.
    lightbulb Created with Sketch. 242
    "they just need the phase 3 interim read-out to demonstrate that the efficacy is also statistically significant"
    you don't understand how futility analysis works. Read this:
    http://onbiostatistics.blogspot.com/2012/03/futility-analysis-in-clinical-trials.html
    even if the independent committee says it is OK to proceed with rest of the trial in a few weeks, that does not mean the results seen are at all "statistically significant" (as in p less than 0.05 as the accepted benchmark). it does not even mean the final results in a few years will be successful.

    gotta love this site, some of the strange beliefs and myths you read- just love coming here. there's one bozo in one of the threads claiming that the asset can be commercialized after a successful futility analysis in a few weeks. and now we have some people looking at how somebody smiles on YouTube video as clues to whether there's a deal- just BRILLIANT.

 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
39.0¢
Change
-0.010(2.50%)
Mkt cap ! $217.3M
Open High Low Value Volume
40.0¢ 40.5¢ 39.0¢ $370.0K 934.6K

Buyers (Bids)

No. Vol. Price($)
2 25531 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 7985 1
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.